Ceptaris Therapeutics, Inc.,
Latest round
- Series D
Last raised
- May 2012
Total raised
- $30M
Investors
- 9
About Ceptaris Therapeutics, Inc.,
, formerly known as Yaupon Therapeutics Inc. is a privately held, specialty pharmaceutical company, is developing a proprietary formulation of mechlorethamine gel for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma.
Who invested in Ceptaris Therapeutics, Inc.,
9 investors across 4 rounds
See all investors in Ceptaris Therapeutics, Inc.,
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ceptaris Therapeutics, Inc.,
Who invested in Ceptaris Therapeutics, Inc.,?
Ceptaris Therapeutics, Inc., has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ceptaris Therapeutics, Inc., raised?
Ceptaris Therapeutics, Inc., has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Ceptaris Therapeutics, Inc., last raise money?
Ceptaris Therapeutics, Inc.,'s most recent round on record is a Series D, in May 2012.
What does Ceptaris Therapeutics, Inc., do?
, formerly known as Yaupon Therapeutics Inc.
Where is Ceptaris Therapeutics, Inc., headquartered?
Ceptaris Therapeutics, Inc., is headquartered in Malvern, US.
Which VCs invest in companies like Ceptaris Therapeutics, Inc.,?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ceptaris Therapeutics, Inc.,'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Ceptaris Therapeutics, Inc.,? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.